Alwine Schulze Elfringhoff

Design and Synthesis of 1-Indol-1-yl-propan-2-ones as Inhibitors of Human Cytosolic Phospholipase A₂α

Joachim Ludwig, Stefanie Bovens, Carsten Brauch et al. · Journal of Medicinal Chemistry · 2006 · 70 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

1-(5-Carboxyindol-1-yl)propan-2-one Inhibitors of Human Cytosolic Phospholipase A₂α with Reduced Lipophilicity: Synthesis, Biological Activity, Metabolic Stability, Solubility, Bioavailability, And Topical in Vivo Activity

Andreas Drews, Stefanie Bovens, Kirsten Roebrock et al. · Journal of Medicinal Chemistry · 2010 · 44 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A2α and fatty acid amide hydrolase

Laura Forster, Joachim Ludwig, Martina Kaptur et al. · Bioorganic & Medicinal Chemistry · 2009 · 36 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +10

1-(5-Carboxyindol-1-yl)propan-2-one Inhibitors of Human Cytosolic Phospholipase A₂α: Effect of Substituents in Position 3 of the Indole Scaffold on Inhibitory Potency, Metabolic Stability, Solubility, and Bioavailability

Stefanie Bovens, Alwine Schulze Elfringhoff, Martina Kaptur et al. · Journal of Medicinal Chemistry · 2010 · 32 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2α: Synthesis, biological activity, metabolic stability, and solubility

Alexandra Fritsche, Alwine Schulze Elfringhoff, Jörg Fabian et al. · Bioorganic & Medicinal Chemistry · 2008 · 31 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +8